Amano Enzyme opens new office in Thailand to serve Southeast Asia and India
Amano Enzyme is opening a new office in the Bangkok Metropolitan Region of the Kingdom of Thailand.
Photo © iStockphoto.com/holgs
Amano Enzyme (Elgin, IL), a worldwide manufacturer and supplier of microbial enzymes, is opening a new office in Thailand. Located in the Pathum Thani province, just north of Bangkok, the office will provide sales, and research and development services to Southeast Asia and India, effective February 1, 2019.
“The new office is being opened to support the growing need for our products and services in this region,” said Ken Iritani, vice president, technical services for Amano, in a press release. “The global food enzyme market is projected to increase at a compound annual growth rate of 6.9% over the next five years, and the Asia-Pacific market is expected to show substantial growth as a result of that trend.”
Kimihiko Sato, who previously served as Amano’s manager of international sales and marketing, food and industrial enzyme division, will be the managing director of the new office.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
